about
Drug-drug interactions among recently hospitalised patients--frequent but mostly clinically insignificantCombination therapy with acetylsalicylic acid and non-aspirin nonsteroidal anti-inflammatory drugsAntidepressants and the risk of hyponatremia: a Danish register-based population studyA multidisciplinary intervention to reduce infections of ESBL- and AmpC-producing, gram-negative bacteria at a University Hospital.Clinical pharmacist service in the acute ward.Adverse effects associated with high-dose olanzapine therapy in patients admitted to inpatient psychiatric care.Hypoglycaemia when adding sulphonylurea to metformin: a systematic review and network meta-analysis.Clinical Effects of a Pharmacist Intervention in Acute Wards - A Randomized Controlled Trial.A Regional Drug and Therapeutics Committee-led Intervention to Reduce the Hospital Costs of Expensive HIV Drugs.Opioids in hip fracture patients: an analysis of mortality and post hospital opioid use.Implementing a new drug record system: a qualitative study of difficulties perceived by physicians and nurses.The prescribing pattern of a new antipsychotic: a descriptive study of aripiprazole for psychiatric in-patients.[Selective serotonin reuptake inhibitor induced hyponatremia].A prospective study of patient adherence to topical treatments: 95% of patients underdose.[Impotence caused by Methotrexate treatment].Assessment of drug treatment quality in two Danish health-care centres.Danish physicians' preferences for prescribing escitalopram over citalopram and sertraline to treatment-naïve patients: a national, register-based study.[Drug dispensing errors].Effects on renal sodium and potassium excretion of vasopressin and oxytocin in conscious dogsContinuous servo-controlled replacement of urinary sodium loss in conscious dogs[Drug costs in departments of internal medicine. An analysis of costs for patients and departments][Impotence as adverse effect][Medication problems and risk management][Written documentation of drug prescriptions. Accordance between medical records and dispensing records][Reliability of death certificates. The reproducibility of the recorded causes of death in patients admitted to departments of internal medicine][Implementation of a new prescription system. A qualitative survey of organizational barriers][Drug handling in a legal perspective]Medication history on internal medicine wards: assessment of extra information collected from second drug interviews and GP listsOne in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic[Compliance to drug prescriptions]The role of the glutathione S-transferase genes GSTT1, GSTM1, and GSTP1 in acetaminophen-poisoned patientsDoes the medication pattern reflect the CYP2D6 genotype in patients with diagnoses within the schizophrenic spectrum?[Control charts--a useful graphical tool for the analysis of process variation over time][Patient information leaflets seen through the eyes of patients in a general practice][Benzodiazepines and cyclopyrrolones prior to, during and after hospital admission][Combination therapy with fluconazole and other QTc-prolonging drugs increase the QTc interval]Hospital admission interviews are time-consuming with several interruptions
P50
Q28185473-192EF3DB-34E5-4CA3-BC7A-F9B1EA7A64FFQ28196304-C6845CE0-73D1-45F8-B074-AD7DF9FED4A4Q36920010-7E9F57C8-2C0A-4850-81DE-16306F2989FCQ37510069-B5496045-3EE1-4AEC-913E-3FE8D13A4499Q38131739-CAEAF84F-9ACC-4915-BB95-17E050297686Q38169238-8B6E9E89-8455-44D4-8AE5-525AD4B2E10BQ38899869-24D09313-49F9-4F6B-A979-862C8A30805CQ39272865-8D125372-D016-4B56-A6E6-65C369AE55D3Q40743211-F658C573-2162-4E0F-B8C6-57A00B661A81Q40964076-3162F4AA-4F55-4318-90CF-FBB47E29A19FQ43063061-C9AA6D77-EF69-4DE3-A74A-8D5C9AA070E7Q44243570-8DC866D8-34E0-4D28-8442-3361EB291366Q44618539-AE55045E-E66E-425E-8E13-9626B523A85CQ45714345-2C5270FC-98AE-4FC3-93E9-BFDFA4D20ACAQ46770454-4BD70EAD-548F-47D7-A247-DF5441E59ED5Q46800039-35E75E80-A143-4CAB-B89C-9B3F3D7B56DCQ50557634-6A076F47-E453-44CB-97F1-1A759160C9F7Q52000059-4F7F7EAA-C4C2-472D-A708-A83F44354124Q68037555-DDD8906C-EBE2-4A51-A9AA-EAE4643ECC20Q68887188-2039B1B7-F52A-4DC6-86B8-215E864AB18FQ73318872-EBE67429-4031-45E9-9E79-E07A10086851Q74236105-0F8619AB-194C-405A-9867-427D90BCAB57Q74600713-1E726884-F266-4924-8136-7981BADD9975Q74769885-08D66B74-D1F5-48BC-AF98-91B6D1CB833FQ77307189-B1D5F8BD-CA1C-467D-B9B5-FDF6A5817800Q78323321-FC918D9B-C9B3-4A74-8AD8-FFC5C8B7D1BFQ78373145-6635A009-F6EB-4776-BD6D-7A6776577149Q79089389-8A31D860-9A70-4C13-BE55-BF32BB969A8CQ81242273-EB2BB03E-9AA0-476C-94C0-70FDB2897F28Q81362581-2420B7DD-CE3C-4BB1-82A4-15BEF189EC11Q82994713-00483FD2-2C00-4FC2-95C6-55FBA5142362Q83133081-4DCA7C66-258F-4C68-9BB2-D1398395D17CQ83462227-745BE425-7021-470A-B1C2-E0173FF92C56Q83473071-25B45581-9554-474A-8E20-E571FAC5E697Q84357468-7520F692-93EB-4579-B751-FA91D2C413D4Q95450287-486C46B3-0638-434B-A3EE-ED9C677F5D56Q95481314-6008571E-D8C3-47F4-802F-912698AD0064
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Andersen SE
@ast
Andersen SE
@es
Andersen SE
@nl
Stig Ejdrup Andersen
@en
type
label
Andersen SE
@ast
Andersen SE
@es
Andersen SE
@nl
Stig Ejdrup Andersen
@en
altLabel
Andersen SE
@en
prefLabel
Andersen SE
@ast
Andersen SE
@es
Andersen SE
@nl
Stig Ejdrup Andersen
@en
P108
P31
P496
0000-0002-1914-4720